{"name":"Fresenius Medical Care Deutschland GmbH","slug":"fresenius-medical-care-deutschland-gmbh","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Solution for Peritoneal Dialysis","genericName":"Solution for Peritoneal Dialysis","slug":"solution-for-peritoneal-dialysis","indication":"Peritoneal dialysis for patients with end-stage renal disease","status":"phase_3"}]}],"pipeline":[{"name":"Solution for Peritoneal Dialysis","genericName":"Solution for Peritoneal Dialysis","slug":"solution-for-peritoneal-dialysis","phase":"phase_3","mechanism":"This solution helps remove waste products from the blood by exchanging fluids in the peritoneal cavity.","indications":["Peritoneal dialysis for patients with end-stage renal disease"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxPaXNsZGxiaWU3R0ZYV0hJREppc2ZfZzRPUkNhb2NRbTFkalJlZUtPYTY5NGkwMEI0ZC1rYUV0WW1vZXBhaVpiREc3bW5KUDBBV2VJbV9WR2xpaGgzaXBlSGVPN1dFcVZWWThUYi1oS01yTEVaWmhzOTlIUVQ4UkdiZUNWUm1kNV9IQ0x0ZXFJa2tQQ3puTEJGa0Z4b3dCQ3Z4bldha3lJVWF0SV9zY3J3RFF3T1UzU29fYWNJalZTUTNWTm1yNUdSMA?oc=5","date":"2026-04-08","type":"pipeline","source":"European Medical Journal","summary":"Reframing Vasoplegia: From Pathophysiology to Targeted Therapy in the ICU - European Medical Journal","headline":"Reframing Vasoplegia: From Pathophysiology to Targeted Therapy in the ICU","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxOT0RfRngtTjZlZzNFU1RXbjJNVG9rYVZ6S3JrWjVST3cyb0w4ZUg1elhzbTc4QzNmRllYVjlQd2FheTRDSUlZaUw3UEZNbzVBYTE4S0NualhLSnZ5aDJfM3ozdGRLNnFUMmRZSGRncG40YldsN2t6TklaTEpqSjRaemsteUlNcERRNHFLOVVQRnNLUm5HZ0E?oc=5","date":"2026-04-08","type":"pipeline","source":"openPR.com","summary":"Anemia in the Elderly Market: Industry Overview, Emerging Trends, and Key Player Analysis - openPR.com","headline":"Anemia in the Elderly Market: Industry Overview, Emerging Trends, and Key Player Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxNRGxKcnpoRDZnTUxYemxLVVdPSHVqd0hnZVpIeC1YX29HWV9UUkFRTmxvclVSaUxmWGR4YmVST0pDNWYwQlZNNXE2aEYyOWVqek56WUVPbFotMzNhcW0tVlVWSF9zZlpZSTliYV9xT3dFeVFFTUpfWWVyVVNQYUNJaWxfT2w4Wi1vNDlCUF83NEpBVXlFSHJia1Nwbw?oc=5","date":"2026-04-06","type":"pipeline","source":"openPR.com","summary":"CRBSI Treatment Market Across the 7MM Expected to Expand at - openPR.com","headline":"CRBSI Treatment Market Across the 7MM Expected to Expand at","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxPMy10bVFCZVpZT2R5R0dsMXBUZ3JmS3U3emxuOFVjNDJNa3NCZ2tzYmhYZFFTajRsM25nSll5clBEalp0cS12V1A3MGZzZl9HOTkycDlHamMzelBWelRMZ3BLNXNqNjNXMGpFMGkyOE1ZUEV6OFV2cTNJX1dOYmNhYXJsWWZSTkQ2TTQ3YTZrRkdpWnNPRzJKOFpqcUo0YWdDQWNaamMzR0dlQ1J3U3hMQmNPd192bVhobU9JVzMtdkRBS015bmN0M1JvWUZpQmI4cWRJ?oc=5","date":"2026-03-10","type":"pipeline","source":"S&P Global","summary":"Issuer Ranking: EMEA Health Care Services Companies, Strongest To Weakest - S&P Global","headline":"Issuer Ranking: EMEA Health Care Services Companies, Strongest To Weakest - S&P Global","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxOUnF1SVVIRnNRNEFyNVY4VllvMzFCclk4Q3FweC1qaUJMSE54QWdOQWpURWRfOGJQQXBHVGlnd0FqTGFlMDB2eE5YNVFSOHduZ2NWMVJYbmE4ZFRyTE1OVGZUaF9GVk9LUVRsQVlBelhmWkt6Y1JodThQcHpqREhBdDF0UGFIeDJzeE1FMHg1c2FjOVM3XzBjenZrTTY?oc=5","date":"2025-10-12","type":"pipeline","source":"Frontiers","summary":"Case Report: Management of a delayed type III hypersensitivity reaction with acute kidney injury in a dog after administration of human serum albumin with immunoadsorption - Frontiers","headline":"Case Report: Management of a delayed type III hypersensitivity reaction with acute kidney injury in a dog after administ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxQbjBwT1pjRlRzUzhmcFZENFg5REhTa1hUZVAxeFR5aHVRdWlieHdmZElUcDJNN0pvZEN1aUYzTHBGRWVnWTRCSTRoUFpiSkRCTUNlOTluMGExdjE0RG83eHdUWUxZa3lmUUllZTktTjFVRGJVTDExRThhMU8tc0xfWU5qYUtHaW1mcml4VnhwcmFBV0txVy1vcUJiUXFVUzBWN2VVYnFORHpva0hqeXBMNA?oc=5","date":"2025-10-09","type":"pipeline","source":"Businessday NG","summary":"No arbitrable dispute exists where a party admits liability - Businessday NG","headline":"No arbitrable dispute exists where a party admits liability","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxOeDFtamxGWjR5bm1DbnMwbkxjNzdad3VMaFhqbnBZZVRBLWEybmxXX3BkRTl2U0JIVVN5eDVuR3F4SHZIZ3cwVXFuUEpnb0pxeDhjNE93dVJubm9Da2IxUlIyanlFNFNGWVZnR29TZzNqRGhldnQ4Q1I3Zms0alowRGZlR3JUQklZb3ZhRGREYUxtR0J0YlFBNkpvODllejA0YzlhcDhzRlZGQ2JBTGZTQk9CMVlZMG1mYkljb0k2NXBOd0tOWUNKdVNGRlZoYzhNcGNSMTl2QWE2S1l6aXVqVmxBQQ?oc=5","date":"2025-05-19","type":"regulatory","source":"businesswire.com","summary":"FDA Grants Interchangeable Designation to Fresenius Kabi’s biosimilar Otulfi® (ustekinumab-aauz) - businesswire.com","headline":"FDA Grants Interchangeable Designation to Fresenius Kabi’s biosimilar Otulfi® (ustekinumab-aauz)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxNSVJMWFgycjJiX3NrNVZuVlZTUFdUUjZ5WXROY2Z1LTFxQ3RUYnpXdld3YWpjQjJzcXRoVzI2aThEaGIxaWI3czI5R01qSlQxMmJjeXp6X044VHhwSE9TYjQzcWlpQnFhXzB4dzBES3hkNE1ONzBtcXdEMmRlc2d1LTI5NWE1OW14YTQxZjNubkE?oc=5","date":"2025-02-25","type":"pipeline","source":"SEC.gov","summary":"FRESENIUS MEDICAL CARE AG_December 31, 2024 - SEC.gov","headline":"FRESENIUS MEDICAL CARE AG_December 31, 2024","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxOc014cmlWSFFocE5MVTI4cGhwLS1uMnBYeE1DOVNiZFVqem1mTFkxc2FydkJBUXlZdVhDVkZwQ1NBSllVT0JMZDF0S0xqU3ZwMWpnUnNfSGdSTEdwYjRhSFowYnR4bnRYQjhKLU5DNFBXYm95RUFNa0hkM21sdW5UeHQ0aFRlRUpQQ2RiRWFHN3d4d3RPNFF1TXJzQ05DNTZ1OTkwUVFHazBoS3BpQ2Y3X2xTaTgzOVF5dnN2YVlzV1Nzdw?oc=5","date":"2023-12-08","type":"pipeline","source":"Reuters","summary":"Fresenius plans to sell rehabilitation care clinics - FAZ - Reuters","headline":"Fresenius plans to sell rehabilitation care clinics - FAZ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE1wYWlyaTJNNjB3UGxyRkxkMmtNUjAwS2NFMFR0UU5RejFxS0ViSzROQS1RWVV1d01aRDk2NFkydUNpZFhHQTJWaDJwVjNjUnFmdmc4aFd3aXBicFRvWjFaV2d3RjJmTHNVM3VaanZLNF9CZ0ZWSnA4?oc=5","date":"2023-06-01","type":"pipeline","source":"Global Biotechnology Company","summary":"Global Biotechnology Company - Global Biotechnology Company","headline":"Global Biotechnology Company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxQWHkyb2Nod01PZHE3TGt5aGhFV0UzOWsySjgyUXRsa214YU95a2pQTHJGcTlBdV9QX1YwTEdwS2V4Ym1MXzlUakZDaVBtQlpEalFxZUJhb2FtWHRPdTdzdkFBTDd1NjRFanZVY1ktdU8ySG1hRVltRk1sX3RBMmJFM1ViM1gtMngxSWFTRkpwR2FieDAya1F5TzFHb0xPaGRScklUU09maUVHVzhyVlY1QVNMN2pSQUppUjRMV2ZBTjczd1k?oc=5","date":"2023-05-25","type":"pipeline","source":"Reuters","summary":"Fresenius lifts 2023 outlook for hospital drugs unit Kabi - Reuters","headline":"Fresenius lifts 2023 outlook for hospital drugs unit Kabi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE9qd0ZlcTJYUGxNMFJnNkFYbUlRT2I3dXc1SzJrWU1CS0d1bmRaZ1RKYTZYVzcxckxvaGhTaUhySDA3amVILU1HaVJaS3U1M3p6N2FvcldtaUc1V2taTGdITXNwN195eWJsRWlqXw?oc=5","date":"2021-06-02","type":"pipeline","source":"Wiley Online Library","summary":"Journal of the European Academy of Dermatology and Venereology - Wiley Online Library","headline":"Journal of the European Academy of Dermatology and Venereology","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}